Lequier Laurance, Joffe Ari R, Robertson Charlene M T, Dinu Irina A, Wongswadiwat Yuttapong, Anton Natalie R, Ross David B, Rebeyka Ivan M
Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
J Thorac Cardiovasc Surg. 2008 Oct;136(4):976-983.e3. doi: 10.1016/j.jtcvs.2008.02.009. Epub 2008 Jun 2.
Comprehensive outcome assessment of children receiving cardiac extracorporeal life support.
From 2000 to 2004, 39 consecutive children (aged 1 day to 4.4 years) had cardiac extracorporeal life support. Neurodevelopmental follow-up of all survivors was performed more than 6 months after life support (aged 53 +/- 12 months). Developmental delay was defined as a score of less than 70 on the Bayley Scales of Infant Development II or Wechsler Preschool and Primary Scale of Intelligence. Predictor variables for mortality (at 2 years' follow-up) and delay were examined by univariate and multivariate analyses.
Indications for extracorporeal life support were progressive low cardiac output in 14 (36%), failed weaning from cardiopulmonary bypass in 13 (33%), cardiac arrest in 9 (23%), and hypoxia in 3 (8%). Cardiac anatomy was single ventricle in 16 (41%), biventricular in 21 (54%), and myocarditis in 2 (5%). Survival was 18 (46%) at hospital discharge and 16 (41%) at 2 years. In survivors, mental score was 73 +/- 16 (normal 100 +/- 15), and 8 (50%) had mental delay. Initiating extracorporeal life support during cardiopulmonary resuscitation and duration of this resuscitation were not associated with death or mental delay. On multivariable Cox regression, lactate on admission to the pediatric intensive care unit (hazard rate 1.13; 95% confidence intervals 1.08-1.27) and single ventricle anatomy (hazard rate 3.93; 95% confidence intervals 1.62-9.49) were associated with death at 2 years. Stepwise multiple regression found time for lactate to normalize on extracorporeal life support, highest inotrope score during 120 hours of life support, and chromosomal abnormality explained 76.7% of the variance in mental score.
Cardiac extracorporeal life support had a 41% 2-year survival. Potentially modifiable variables (time for lactate to normalize and highest inotrope score early during extracorporeal life support) explained 69% of mental score variance.
对接受心脏体外生命支持的儿童进行综合结局评估。
2000年至2004年,39例连续儿童(年龄1天至4.4岁)接受了心脏体外生命支持。对所有幸存者在生命支持后6个月以上(年龄53±12个月)进行神经发育随访。发育迟缓定义为贝利婴儿发育量表第二版或韦氏学前及初小儿童智力量表得分低于70分。通过单因素和多因素分析研究2年随访时死亡率和发育迟缓的预测变量。
体外生命支持的指征包括14例(36%)进行性低心排血量、13例(33%)体外循环脱机失败、9例(23%)心脏骤停和3例(8%)缺氧。心脏解剖结构为单心室16例(41%)、双心室21例(54%)、心肌炎2例(5%)。出院时生存率为18例(46%),2年时为16例(41%)。幸存者的智力得分是73±16(正常为100±15),8例(50%)有智力发育迟缓。在心肺复苏期间开始体外生命支持及该复苏持续时间与死亡或智力发育迟缓无关。多变量Cox回归分析显示,儿科重症监护病房入院时的乳酸水平(风险比1.13;95%置信区间1.08 - 1.27)和单心室解剖结构(风险比3.93;95%置信区间1.62 - 9.49)与2年时的死亡相关。逐步多元回归分析发现,体外生命支持期间乳酸水平恢复正常的时间、生命支持120小时内最高的血管活性药物评分以及染色体异常可解释智力得分变异的76.7%。
心脏体外生命支持的2年生存率为41%。潜在可改变的变量(乳酸水平恢复正常的时间和体外生命支持早期最高的血管活性药物评分)可解释69%的智力得分变异。